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Occult Cushing's Syndrome Presenting with Osteoporosis
M. Kleerekoper, M D , * Sudhaker D. Rao, MB, BS,* B. Frame, MD,* R.D. LaRocque, M D , '
T. Feigelman, M D , * V. Matkovic, M D , PhD, and L. V. Avioli, M D * * *

Osteoporosis
is a frequent complication
both of endogenous hypercortisolism
and of long-term
treatment
with
corticosteroids,
but only rarely is it the major
clinical
feature with the more characteristic
features absent or
minimally
present. In the two patients presented,
hypercortisolism
was uncovered only during routine
evaluation

of osteoporosis.
This presentation
is probably due to slow
progression of the disease and is often associated with socalled black adenoma
of the adrenal gland.
Secondary
causes should be sought in all patients with
seemingly
"senile"
or "postmenopausal"
osteoporosis.

A c c e l e r a t e d bone loss with symptomatic vertebral compression or long bone fractures is a we 11-recognized and
frequent complication of long-term corticosteroid therapy
(1). In endogenous hypercortisolism (2), osteoporosis is
usually detected after the diagnosis has been established
in patients with more obvious manifestations, such as
amenorrhea, weight gain, or hirsutism. We report two
patients who were referred primarily for evaluation of
osteoporosis. The usual clinical features of hypercortisolism were absent, and the diagnosis was established only
when the urine-free Cortisol was measured during the
evaluation of osteoporosis.

tried but quickly discontinued because of psychotic episodes. In
1961, a total colectomy led to complete resolution of both gastrointestinal and arthritic symptoms. In 1963, after a single episode of right ureteric colic, she passed a stone spontaneously; it
was not analysed. In 1971, hypertension was noted for the first
time. In May 1976, a traumatic fracture of the right inferior pubic
ramus healed well, but the pelvis and lumbar spine were reported
as "demineralized" on x-rays. She had felt vaguely unwell for the
past several years with nonspecific weakness, lethargy, arthralgias
and easy bruising. She denied recent weight gain. The menopause
had occurred five years earlier, and she had taken no estrogen
replacement.
Physical e x a m i n a t i o n revealed moderate obesity, slightly
plethoric face, bruises over both shins, slight wasting of the left
thenar eminence and dorsum of both wrists, and an ileostomy.
Blood pressure was 180/105 mmHg, height 5'3", weight 142y2 lbs.

Case Reports

The x-rays revealed generalized osteoporosis with healed fractures o f t h e right superior and inferior pubic rami without abundant callus. Bone mineral content by photon absorptiometry was
0.513 gm/cm at the proximal site and 0.310 gm/cm at the distal
site ( - 3 . 5 0 SD and - 5 . 0 2 SD, respectively) below the normal
mean value adjusted for age, sex, and race). Serum calcium,
phosphorus, total p r o t e i n , a l k a l i n e phospatase, B U N and
creatinine were all within normal limits. Thyroid function tests
were n o r m a l . A transiliac crest bone biopsy after d o u b l e
tetracycline labeling showed a moderate decrease in the osteoid
surface wth a significant reduction in the osteoblast surface. Total
resorption surface, mineral appositional rate, and bone formation
rate were within normal limits. Urine-free Cortisol excretion obtained as part of the routine workup for osteoporosis was 755
^ig/24 hrs. Because of this unexpected finding, the patient was
asked to bring old photographs of herself; these indicated evolving, mild Cushing's syndrome. Plasma Cortisol was 15.5 /xg/dl at
8 a.m. and 16.2 ju.g/dl at 4 p.m., indicating loss of normal diurnal
variation. Two mg of dexamethasone failed to suppress the urine-

Case 1
A 52-year-old white woman was referred to Henry Ford Hospital
for evaluation of osteoporosis in August 1976. In 1954, she had
developed ulcerative colitis during the eighth month of her
second pregnancy, f o l l o w e d by postpartum septicemia and
pyoderma gangrenosum. Between 1954 and 1961, the ulcerative
colitis responded poorly to azulfidine. There were several episodes of acute arthritis of both hands. Corticosteroid therapy was
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ACTH was 82 pg/ml in the morning and 220 pg/ml in the
afternoon. The visual fields were normal.

free Cortisol excretion (Table 1). ^"1 iodocholesterol scan revealed
an adenoma o f t h e right adrenal gland with contralateral suppression of the left adrenal gland. The right adrenal gland was
removed; it weighed 8.5 gms and contained a cortical adenoma
with black pigment—the so-called black adenoma ofthe adrenal
(3). There was no evidence of micronodular hyperplasia. She
required treatement with ACTH for ten months before normal
adrenal function was restored. A compression fracture o f t h e L-1
vertebra occurred one month after surgery, but she was subsequently free of backache.

In September 1976, he was referred to Berkeley California for
heavy particle i r r a d i a t i o n and was also started on Elipten
(a-glutethimide) 250 mg three times a day. After this treatment,
his bone pain decreased, he felt better, and was able to move
about more easily. Over the next six months, plasma Cortisol
decreased to 9 fLg/d\, urine-free Cortisol to 68 /xg/24 hrs, and
urine calcium 111 mg/24 hrs. There was no recurrence of fractures
or kidney stones.

When last seen in January 1980, she had lost the Cushingoid
appearance. Her weight was 133 lbs ( - 9 lbs), height 5 ' 2 " (-1"),
and there was no significant change in her bone mineral content.
Her blood pressure was normal without any antihypertensive
therapy. Urine calcium excretion declined progressively (Table I)
without further stone episodes.

Laboratory Methods
Serum calcium, phosphorus, total protein, alkaline phosphatase, BUN and creatinine were measured by routine
autoanalyser methods. Urine calcium was measured by
atomic absorption spectrometry (normal OOO mg/24 hrs,
for men and <250 mg/24 hrs for women on regular home
diet). In Case 1, plasma Cortisol and urine-free Cortisol were
measured by radioimmunoassay (RIA) using a commercially available kit (normal ranges for plasma 7-25 ^tg/dl
(a.m.) and 7-9 jug/dl (p.m.) and for urine 20-90 p.g/24 hrs).
Plasma ACTH was measured by RIA (Sera Inc, Columbus,
O h i o , n o r m a l range 15-80 p g / m l ) . U r i n e 17 hydroxy
steroids were measured by the Porter-Silber method (normal range 4-12 mg/24 hrs). The investigations in Case 2
were performed at different institutions, but the normal
ranges were about the same as in Case 1.

Case 2
A 62-year-old white man was referred to The Jewish Hospital of
St. Louis for evaluation of osteopenia in November 1975. During
the previous two years he had sustained several compression
fractures of the vertebrae with 6y2"loss in height, several fractures
of the ribs, and a pathologic fracture of the right inferior pubic
ramus and right acetabulum. Ureteric colic due to stones had
occurred in 1951, and again in 1961, when a nephrostomy was
performed for left hydronephrosis. The stone was composed of
calcium oxalate. He did well on a low calcium and oxalate diet,
except for one further episode of ureteric colic in 1974. His father
and sister also had kidney stones.
On physical examination, none ofthe usual features of hypercortisolism were present, except for thin and atrophic skin and
several purpuric lesions on both hands. Several angiomata were
seen on the torso, and the extremities were thin with muscle
wasting. Blood pressure was 140/80 mmHg.

Discussion
The usual clinical features of hypercortisolism (both exogenous and endogenous) include marked obesity, moon
face, pinkish striae, hypertension, diabetes, and hirsutism.
Although common, osteoporosis receives little attention; it
can occur in all forms of corticosteroid excess, including
the ectopic ACTH syndrome (4).

X-rays confirmed the old pelvic fractures, compression fractures
ofthe Sth and 11th thoracic and 4th lumbar vertebrae and several
rib fractures. Serum calcium, phosphorus, alkaline phosphatase,
total protein, BUN, creatinine, fasting blood sugar were all within
normal limits. Urine calcium excretion was 333 mg/24 hrs.
Immunoreactive parathyroid hormone level was 6 /uLEq/ml (norm a l - 8 /aLEq/ml). Plasma Cortisol was 14.7 /xg/dl at 8 a.m. and
2.3 /ag/dl at 4 p.m., which was a normal diurnal change; but
urine-free Cortisol excretion was 170 and 166 /Ag/24 hrs. After
2 mg of dexamethasone, urine-free Cortisol fell to 64 /i.g/24 hrs,
and after 8 mg to 32 fi.g/24 hrs (Table II). A transiliac crest bone
biopsy showed increased numbers of osteoblasts and osteoclasts;
tetracycline uptake was depressed, suggesting diminished new
bone formation.

The effects of hypercortisolism on bone and mineral metabolism are varied both in scope and severity. They include growth retardation in children (5), osteoporosis in
adolescents and adults (2,6), w i t h d i s p r o p o r t i o n a t e l y
greater trabecular bone loss (7), and aseptic necrosis o f t h e
femoral or humeral head in adults (8). About 20% of
patients with endogenous hypercortisolism have nephrolithiasis (9,10), and they usually have osteoporosis as well
(10). Radiographic nephrocalcinosis is rare, but histologic
nephrocalcinosis is more common than nephrolithiasis (9).
For unknown reasons nephrolithiasis is rare in exogenous
hypercortisolism.

Calciferol 1.25 mg twice weekly and hydrochlorothiazide 50 mg
twice daily were started. Later, because of hypercalcemia, the
doses were reduced to 1.25 mg weekly and 50 mg three times
weekly, respectively. A repeat dexamethasone suppression test
confirmed the previous findings, and plasma ACTH was raised
(Table II). Because he was a poor operative risk, he was treated
with ortho-para D D D (mitotane) 4.5 gms/day for six weeks. The
plasma Cortisol and urine-free Cortisol levels remained elevated.

The adverse effects of corticosteroid excess on bone and
mineral metabolism are mediated by several mechanisms,
including decreased intestinal calcium absorption leading
to secondary hyperparathyroidism (11), decreased renal
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TABLE I
Endocrine Studies
Case 1
Plasma
Cortisol
(ftg/dl)
a.m.
p.m.
Control
Control
Control
Control
6 hr infusion
Control
Control
Dexame* 2 mg/day
Dexame
2 mg/day
Dexame
8 mg/day
Dexame
8 mg/day
Metyrapone 750 mg x 6
day #1
day #2

ACTH I.M. 40 units

ACTH I.M. 40 units
Off ACTH but while on
replacement therapy

ACTH
(pg/ml)

12-13-76
2-2-77
3-3-77
3-11-77

24.1
15.5
18.5
19.3

49

3-11-77
4-2-77

21.5
18.3
18.4

53

4-3-77
4-4-77
4-5-77
4-6-77
4-7-77
4-8-77
4-9-77
4-10-77
4-11-77

Right Adrenalectomy

Urine

5-16-77
9-20-77
11-20-77
11-21-77
11-23-77
11-24-77
11-26-77
11-27-77
2-13-78
1-6-79

17-OHCS
(mg/24 hr)

590
655
530
624

16.4

134

16.3
17.8
17.9
18.3
15.8
10.3
15.0

82

6.0

63

479
463
29

Ca
(mg/24 hr)
294
229

755

17.5
19.4
16.2
15.3

12.6

Free Cortisol
(Mg/24hr)

4.3

10.4
4.4

5.5
2.4

2.0
10.4
9 5

2.9
2.2

21.6

7.0

157

6.0
7,0

46
34
91

2-14-79
1-22-80
* Dexamethasone

tubular reabsorption calcium leading to hypercalciuria
(11,12), and decreased bone formation and increased bone
resorption (13,14). All these effects contribute to a net
negative calcium balance that leads to osteoporosis and, in
some patients, to nephrolithiasis.

patients had nephrolithiasis in a d d i t i o n to severe osteoporosis, and the first patient was initially thought to have
primary hyperparathyroidism (15).
Adrenal pathology was available in five of the seven cases.
The remaining two patients were thought clinically to have
bilateral adrenal hyperplasia. Blackor brown pigmentation
was found in three, but no mention was made in the other
two. "Black adenoma" (or hyperplasia), previously thought
to be nonfunctional, is now recognized as a distinct clinical
entity which may be associated with either hypercortisolism or aldosteronism (17,18). The deposition of pigment
(black, brown, or blue) in the adrenal gland is believed to
represent an " e x h a u s t i o n " or " w e a r and t e a r " phenomenon (19) that indicates a long-standing disease pro-

Both of our patients were referred initially for evaluation of
severe osteoporosis and nephrolithiasis. The usual signs of
hypercortisolism were minimal or absent, and the diagnosis was made during a routine screening for other causes
of osteoporosis. Besides these two cases, five other patients
have been reported (4,6,15,16) with skeletal symptoms as
the major presenting feature of hypercortisolism (Table III).
The duration of skeletal symptoms before the diagnosis of
hypercortisolism was two to seven years. Two ofthe seven
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TABLE II
Endocrine Studies
Case 2
Plasma

Control
Control
Dexame*
Dexame
Dexame
Dexame
Control
Dexame
Dexame
Dexame
Dexame

2
2
8
8

2
2
8
8

mg/day
mg/day
mg/day
mg/day

mg/day
mg/day
mg/day
mg/day

Control
Metyrapone 750 mg x 6
day #1
day #2
Control
Control
Alpha 1-24 ACTH I.V
0 min
30 min
60 min

11-17-75
11-18-75
11-19-75
11-20-75
11-21-75
11-22-75
2-11-76
2-12-76
2-13-76
2-14-76
2-15-76
2-16-76
2-17-76
2-18-76
2-19-76
2-20-76
2-21-76
4-13-76
4-14-76
4-15-76
(basal)

9-6-76
9-7-76
Proton beam irradiation
of pituitary

Dexame

1 mg/overnight

Dexame

1 mg/overnight

Dexame

1 mg/overnight

9-10-76
10- 29-76
11- 18-76
12- 29-76
3-17-77
3- 23-77
4- 18-77
4-20-77
6-8-77
6-9-77

Cortisol
(Mg/dl)
a.m. p.m.
14.7
2.2

16.0

Urine
ACTH
(pg/ml)
a.m. p.m.

Free Cortisol
(Mg/24hr)

17-OHCS
(mg/24 hr)

170
166
64
32
25
13

26.0

314

333
299

12.6

11.5

140

7.3

<2.0

60

2.C

20.0
16.0

17

15.5 13.7
23.0
39.0
54.0
29.0
28.7

140

150

Ca
(mg/24 hr)

1029

2.0
30.0
18.0
18.0

553

15.3

26.0 (after overnight 1 mg Dexame suppression)
25.8

107

111

22
23
16
;5
9
8
10
6

• Dexamethasone

cess. This would explain the milder symptoms and signs of
hypercortisolism in patients presenting with skeletal manifestations, as well as the frequent finding of pigmented
adrenal glands. Apparently, the clinical effects of corticosteroid excess, as ofother endocrinopathies, vary with the
rate of progression. Rapid progression, as in some patients
with the ectopic ACTH syndrome, causes predominant

electrolyte disturbance, whereas " n o r m a l " progression
gives rise to classic Cushing's syndrome, and slow progression to predominant osteoporosis (Table IV).
Physicians should always suspect hypercortisolism in patients with unexplained osteoporosis, especially when the
loss of bone is more severe than would be expected for
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T A B L E III
S e v e n Patients with Hypercortisolism and O s t e o p o r o s i s
D u r a t i o n of
Skeletal

Case/Age/Sex

Presenting Feature

Symptoms

X-Ray Findings

Initial Clinical
Diagnosis

Adrenal

Pathology

1/41/M (15)

Back pain, loss of height

2 years

Multiple rib and
vertebra compression
fractures

Primary
hyperparathyroidism

Bilateral
micronodular
hyperplasia;
pigment not
mentioned

2/19/M (6)

Chronic back pain

2 years

Vertebral
compression
fractures

Idiopathic
osteoporosis

Micronodular
adrenal disease
with brown
pigment

3/23/F (6)

Spontaneous rib
fracture

3 years

Multiple rib fractures

Idiopathic
osteoporosis

Micronodular
adrenal disease
with black
pigment

4/46/M (16)

Right hip pain

7 years

Multiple rib fractures,
aseptic necrosis of
femoral head

Aseptic necrosis of
femoral head

Not available;
hyperplasia by lab
evidence

5/64/F (4)

Back pain, rib fractures,
purpuric skin lesions

2 years

Multiple rib and
vertebral
compression
fractures

Metastatic medullary
thyroid carcinoma

Bilateral cortical
hyperplasia;
pigment not
mentioned

6/52/F
(Case 1)

Back pain, kidney
stones

2 years

Healed fracture of
right inferior pubic
ramus

Postmenopausal
osteoporosis and
nephrolithiasis

Right adrenal
black adenoma

7/62/M
(Case 2)

Spontaneous rib
fractures, kidney stones

2 years

Multiple fractures of
ribs, vertebrae, pubic
rami and acetabulum

Idiopathic
osteoporosis

Not available; see
text

T A B L E IV

their age and sex. It is important to avoid delay in diagnosis, since osteoporosis in this disease is preventable but
not reversible (2). Urine-free Cortisol is a more sensitive test
than the plasma Cortisol, because it is an index of the
integrated Cortisol secretion rate. This test should be obtained routinely as a part o f t h e evaluation of osteoporosis.

Relationship Between Progression of the D i s e a s e and Clinical
Manifestations in Patients with Hypercortisolism

Progression

Clinical Presentation

Rapid

Hypokalemia

Ectopic ACTH
syndromes

"Normal"

Classic Cushing's

"Usual" (adenoma
or hyperplasia)

Slow

Osteoporosis and/or
nephrolithiasis

Pigmented (adenoma
or hyperplasia)

Adrenal Pathology
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